Therapeutic Asset Ratings

567 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Thiotepa Lymphoplasmacytic Lymphoma	Fred Hutchinson Cancer Center	P2	B (57)
Thiotepa Myelodysplastic Syndrome With Excess Blasts	Fred Hutchinson Cancer Center	P2	B (57)
Thiotepa Prolymphocytic Leukemia	Fred Hutchinson Cancer Center	P2	B (57)
Thiotepa Myelodysplastic Syndrome With Single Lineage Dysplasia	Fred Hutchinson Cancer Center	P2	B (57)
Thiotepa Shwachman-Diamond Syndrome	Fred Hutchinson Cancer Center	P2	B (57)
Treosulfan Congenital Amegakaryocytic Thrombocytopenia	Fred Hutchinson Cancer Center	P2	B (57)
Treosulfan Diamond-Blackfan Anemia	Fred Hutchinson Cancer Center	P2	B (57)
Treosulfan GATA2 Deficiency With Susceptibility To MDS/AML	Fred Hutchinson Cancer Center	P2	B (57)
Treosulfan SAMD9L-Related Spectrum And Myeloid Neoplasm Risk	Fred Hutchinson Cancer Center	P2	B (57)
Treosulfan SAMD9-Related Spectrum And Myeloid Neoplasm Risk	Fred Hutchinson Cancer Center	P2	B (57)
Treosulfan Inherited Sideroblastic Anemia	Fred Hutchinson Cancer Center	P2	B (57)
Treosulfan Paroxysmal Nocturnal Hemoglobinuria	Fred Hutchinson Cancer Center	P2	B (57)
Treosulfan Shwachman-Diamond Syndrome	Fred Hutchinson Cancer Center	P2	B (57)
Busulphan Acute Leukemia Of Ambiguous Lineage	Fred Hutchinson Cancer Center	P2	B (56)
TACROLIMUS Acute Leukemia Of Ambiguous Lineage	Fred Hutchinson Cancer Center	P2	B (56)
CYCLOSPORIN A Acute Leukemia Of Ambiguous Lineage	Fred Hutchinson Cancer Center	P2	CCC (55)
Irinotecan Castration-Resistant Prostate Carcinoma	Fred Hutchinson Cancer Center	P2	CCC (55)
Recombinant Human Granulocyte Colony-Stimulating Factor Chronic Myelomonocytic Leukemia	Fred Hutchinson Cancer Center	P2	CCC (55)
(+)-VINCRISTINE Castration-Resistant Prostate Carcinoma	Fred Hutchinson Cancer Center	P2	CCC (55)
Nivolumab Hormone Receptor-Positive Breast Cancer	Fred Hutchinson Cancer Center	P1/2	CCC (55)
Anakinra B-Cell Non-Hodgkin Lymphoma	Fred Hutchinson Cancer Center	P2	CCC (54)
Nivolumab Cervical Cancer	Fred Hutchinson Cancer Center	P2	CCC (54)
Thiotepa Marginal Zone Lymphoma	Fred Hutchinson Cancer Center	P2	CCC (54)
Treosulfan Chronic Myelomonocytic Leukemia	Fred Hutchinson Cancer Center	P2	CCC (54)
Jcar017 (Lisocabtagene Maraleucel) Indolent B-Cell Non-Hodgkin Lymphoma	Fred Hutchinson Cancer Center	P1/2	CCC (54)

Showing 251 to 275 of 567 assets

PreviousPage 11 of 23Next